Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Daré Bioscience said its Medical Director Annie Thurman will present phase 1 adverse event and relative bioavailability data comparing topical sildenafil cream versus oral sildenafil at the SMSNA annual fall scientific meeting.
Daré Bioscience said it will present Phase 1 data for its sildenafil cream at the Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting.